CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Treatment of Latent Tuberculosis Infection After Re-Exposure: Guidelines

Last updated: July 13, 2020
Project Number: RB1505-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What are the evidence-based guidelines regarding re-treatment of latent tuberculosis infection after exposure to an individual with an active tuberculosis infection?

Key Message

One evidence-based guideline was identified regarding re-treatment of latent tuberculosis infection after exposure to an individual with an active tuberculosis infection.